(E)-4-(2-nitroprop-1-en-1-yl)benzonitrile | 52287-54-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-4-(2-nitroprop-1-en-1-yl)benzonitrile
• 英文别名: (E)-4-(2-nitroprop-1-enyl)benzonitrile；(E)-1-(4-cyanophenyl)-2-nitropropene；4-(2-nitropropenyl)benzonitrile；4-[(1E)-2-nitroprop-1-en-1-yl]benzonitrile；4-((1E)-2-nitro-1-propenyl)benzonitrile；4-[(E)-2-nitroprop-1-enyl]benzonitrile
• CAS: 52287-54-4
• 化学式: C₁₀H₈N₂O₂
• 分子量: 188.186
• InChiKey: QUYFLWCRFTXHIO-SOFGYWHQSA-N

物化性质

• 熔点：
  109 °C
• 沸点：
  353.4±25.0 °C(Predicted)
• 密度：
  1.21±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  69.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-4-(2-nitroprop-1-en-1-yl)benzonitrile 在 yeast 、 水 作用下， 以 Petroleum ether 为溶剂， 反应 24.0h， 以52%的产率得到4-(2-nitropropyl)benzonitrile
  参考文献：
  名称：

  The Yeast-Mediated Reduction of Nitrostyrenes in Organic Solvent Systems

  摘要：

  一系列的硝基苯乙烯已经在有机溶剂体系中与干燥的面包酵母还原。发现还原反应进行顺利，产率较高且效率比对应的水相反应系统更高，没有观察到硝基团的还原证据。对于β-甲基硝基苯乙烯，生成了外消旋混合物，并且证明这不是产物的外消旋化造成的。

  DOI：

  10.1071/ch9961257
• 作为产物：
  描述：

  在 palladium diacetate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 四丁基溴化铵 、 sodium nitrite 作用下， 以 乙二醇二甲醚 为溶剂， 反应 5.17h， 以83 mg的产率得到(E)-4-(2-nitroprop-1-en-1-yl)benzonitrile
  参考文献：
  名称：

  Palladium-catalyzed synthesis of substituted nitroolefins

  摘要：

  A one-pot protocol toward several substituted nitroolefins 4 and 6 starting with substituted acetones 2 and 5 was described. A facile process was carried out for the triflation of substituted acetones 2 and 5 with triflic anhydride (Tf2O) under the basic condition (Cs2CO3) and then palladium-catalyzed cross-coupling of enol triflates 3 with NaNO2 and BINAP in the presence of phase-transfer reagents (n-Bu4NBr) under the refluxing 1,2-dimethoxyethane (DME) in acceptable yields. (C) 2013 Elsevier Ltd. All rights reserved,

  DOI：

  10.1016/j.tetlet.2013.04.038

文献信息

• Synthesis of Nitroalkenes Involving a Cooperative Catalytic Action of Iron(III) and Piperidine: A One-Pot Synthetic Strategy to 3-Alkylindoles, 2<i>H</i>-Chromenes and<i>N</i>-Arylpyrrole
  作者：Swapnadeep Jalal、Soumen Sarkar、Krishnendu Bera、Sukhendu Maiti、Umasish Jana

  DOI：10.1002/ejoc.201300172

  日期：2013.8

  efficient and simple strategy has been developed to synthesize various substituted nitroalkenes involving a cooperative catalytic system of FeCl3 and piperidine. This dual catalytic protocol simultaneously activates both electrophile and nucleophile and works under mild reaction conditions so that many sensitive functional groups were tolerated. Moreover, this cooperative catalytic reaction is also suitable

  已经开发出一种有效且简单的策略来合成各种取代的硝基烯烃，涉及 FeCl3 和哌啶的协同催化体系。这种双催化协议同时激活亲电试剂和亲核试剂，并在温和的反应条件下工作，因此可以耐受许多敏感的官能团。此外，这种协同催化反应还适用于涉及硝基烯烃的各种一锅反应，如2H-色烯、N-芳基吡咯和与吲哚的迈克尔反应。值得注意的是，这种方法成本低、效率高且环保。
• Androgen receptor antagonists
  申请人：Furuya Shuichi

  公开号：US20050101657A1

  公开（公告）日：2005-05-12

  The present invention provides an androgen receptor antagonistic agent and a superior prophylactic or therapeutic agent for hormone-sensitive cancer, which contain a compound of the formula: wherein, R 1 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R 2 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R 3 is a hydrogen atom, a hydrocarbon group which may have substituent(s), an acyl group or a heterocyclic group which may have substituent(s), R 4 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, and R 5 is a cyclic group which may have substituent(s); or a salt thereof, or its prodrug.

  本发明提供了一种雄激素受体拮抗剂，以及一种优越的预防或治疗激素敏感性癌症的药物，其含有式中的化合物：其中，R1是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团，R2是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团，R3是氢原子、可能具有取代基的碳氢基团、酰基或可能具有取代基的杂环基团，R4是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团，R5是可能具有取代基的环状基团；或其盐或前药。
• Substituted Pyrrole Derivative
  申请人：Matsunaga Nobuyuki

  公开号：US20080176906A1

  公开（公告）日：2008-07-24

  The present invention provides a novel pyrrole derivative having excellent androgen receptor antagonism, which is represented by the formula: wherein R 1 represents a hydrogen atom, a cyano group or a group represented by the formula COOR A (wherein R A represents an optional substituted C 1-6 alkyl group), R 2 and R 4 are the same or different, and each represents a hydrogen atom, a C 1-6 alkyl group, a C 3-6 cycloalkyl group, a trifluoromethyl group, an amino-C 1-6 alkyl group, a mono- or di-substituted amino-C 1-6 alkyl group, an optionally halogenated C 1-6 alkyl group substituted with an optionally substituted hydroxyl group, a C 2-6 alkenyl group substituted with an optionally substituted hydroxyl group, a C 1-6 alkyl group substituted with an optionally substituted and optionally oxidized thiol group, an optionally substituted with and optionally oxidized thiol group, a cyano group, an acyl group, an optionally substituted oxazolyl group or a 1,3-dioxolan-2-yl group, R 3 represents a group represented by the formula: (wherein X represents a halogen atom, Y represents a carbon atom or a nitrogen atom, Alk represents an optionally substituted C 1-4 alkylene group, and R B represents a hydrogen atom or an acyl group), and R 5 represents a phenyl group which has a cyano group at a 4 -position or a 3 -position thereof, and may be further substituted, or a salt thereof. The present invention also provides an androgen receptor antagonist containing the pyrrole derivative, or a salt thereof.

  本发明提供了一种新型吡咯衍生物，具有优异的雄激素受体拮抗作用，其化学式表示为：其中，R1表示氢原子、氰基或由COORA（其中RA表示可选的取代C1-6烷基基团）表示的基团，R2和R4相同或不同，每个表示氢原子、C1-6烷基基团、C3-6环烷基基团、三氟甲基基团、氨基-C1-6烷基基团、单取代或双取代氨基-C1-6烷基基团、可选卤代的C1-6烷基基团，其被取代的羟基基团也是可选的、可选取代的C2-6烯基基团、被可选取代的硫醇基团取代的C1-6烷基基团、被可选取代的、可选氧化的硫醇基团取代的C1-6烷基基团、氰基、酰基、可选取代的噁唑基团或1,3-二氧杂环戊烷-2-基基团，R3表示由以下公式表示的基团：（其中，X表示卤素原子，Y表示碳原子或氮原子，Alk表示可选取代的C1-4烷基基团，RB表示氢原子或酰基），R5表示在其4-位或3-位具有氰基基团的苯基基团，可以进一步取代，或其盐。本发明还提供了一种含有该吡咯衍生物或其盐的雄激素受体拮抗剂。
• ANDROGEN RECEPTOR ANTAGONISTS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1466902A1

  公开（公告）日：2004-10-13

  The present invention provides an androgen receptor antagonistic agent and a superior prophylactic or therapeutic agent for hormone-sensitive cancer, which contain a compound of the formula: wherein, R1 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom; R2 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, R3 is a hydrogen atom, a hydrocarbon group which may have substituent (s) , an acyl group or a heterocyclic group which may have substituent(s), R4 is a hydrogen atom, a group binding through a carbon atom, a group binding through a nitrogen atom, a group binding through an oxygen atom or a group binding through a sulfur atom, and R5 is a cyclic group which may have substituent(s); or a salt thereof, or its prodrug.

  本发明提供了一种雄激素受体拮抗剂和一种激素敏感性癌症的高级预防或治疗剂，其中含有一种式化合物： 其中，R1 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团；R2 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合 的基团或通过硫原子结合的基团； R3 是氢原子、烃基，该烃基可能具有取代基（s）、R4 是氢原子、通过碳原子结合的基团、通过氮原子结合的基团、通过氧原子结合的基团或通过硫原子结合的基团，R5 是可能带有取代基的环状基团；或其盐或其原药。
• WO2006/64944
  申请人：——

  公开号：——

  公开（公告）日：——